520
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Extended-Spectrum β-Lactamase and Carbapenemase Producing Gram-Negative Bacilli Infections Among Patients in Intensive Care Units of Felegehiwot Referral Hospital: A Prospective Cross-Sectional Study

, ORCID Icon &
Pages 391-405 | Published online: 02 Feb 2021

References

  • Marshall JC, Bosco L, Adhikari NK, et al. What is an intensive care unit? A report of the task force of the world federation of societies of intensive and critical care medicine. J Crit Care. 2017;37:270–276. doi:10.1016/j.jcrc.2016.07.01527612678
  • Dereli N, Ozayar E, Degerli S, Sahin S, Koç F. Three-year evaluation of nosocomial infection rates of the ICU. Rev Bras Anestesiol. 2013;63(1):79–84. doi:10.1590/S0034-70942013000100006
  • Deptuła A, Trejnowska E, Ozorowski T, Hryniewicz W. Risk factors for healthcare-associated infection in light of two years of experience with the ECDC point prevalence survey of healthcare-associated infection and antimicrobial use in Poland. J Hosp Infect. 2015;90(4):310–315. doi:10.1016/j.jhin.2015.03.00525933918
  • Stocchetti N, Carbonara M, Citerio G, et al. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017;16(6):452–464. doi:10.1016/S1474-4422(17)30118-728504109
  • Khan HA, Baig FK, Mehboob R. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7(5):478–482. doi:10.1016/j.apjtb.2017.01.019
  • Agaba P, Tumukunde J, Tindimwebwa JV, Kwizera A. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes. 2017;10(1):349. doi:10.1186/s13104-017-2695-528754148
  • Akhtar N. Hospital acquired infections in a medical intensive care unit. J Coll Physicians Surg Pak. 2010;20(6):386–390.20642968
  • Kołpa M, Wałaszek M, Gniadek A, Wolak Z, Dobroś W. Incidence, microbiological profile and risk factors of healthcare-associated infections in intensive care units: a 10 year observation in a provincial hospital in Southern Poland. Int J Environ Res Public Health. 2018;15(1):112. doi:10.3390/ijerph15010112
  • Lai CC, Wang CY, Chu CC, et al. Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. J Antimicrob Chemother. 2011;66(6):1374–1382. doi:10.1093/jac/dkr10321436153
  • Sabir R, Alvi SF, Fawwad A. Antimicrobial susceptibility pattern of aerobic microbial isolates in a clinical laboratory in Karachi-Pakistan. Pak J Med Sci. 2013;29(3):851. doi:10.12669/pjms.293.318724353642
  • Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4(148):148ra116. doi:10.1126/scitranslmed.3004129
  • Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012;18(5):439–448. doi:10.1111/j.1469-0691.2012.03823.x22507111
  • É R, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5(1):21.
  • Mehrad B, Clark MN, Zhanel GG, Lynch JP. Antimicrobial resistance in hospital-acquired Gram-Negative bacterial infections. Chest. 2015;147(5):1413–1421. doi:10.1378/chest.14-217125940252
  • Yamachika S, Sugihara C, Kamai Y, Yamashita M. Correlation between penicillin-binding protein 2 mutations and carbapenem resistance in Escherichia coli. J Med Microbiol. 2013;62(3):429–436. doi:10.1099/jmm.0.051631-023222859
  • Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Et Maladies Infect. 2014;44(2):51–56. doi:10.1016/j.medmal.2013.11.007
  • Rello J, Eshwara VK, Lagunes L, et al. A global priority list of the top ten resistant microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis. Eur J Clin Microbiol Infect Dis. 2019;38(2):319–323. doi:10.1007/s10096-018-3428-y30426331
  • Venkatasubramanian P, Balasubramani SP, Patil R. “Planetary Health” perspectives and alternative approaches to tackle the AMR challenge. Antimicrob Resist. 2020;165–188.
  • Arora A, Jain C, Saxena S, Kaur R. Profile of drug resistant Gram negative bacteria from ICU at a tertiary care center of India. Asian J Med Health. 2017;18:1–7. doi:10.9734/AJMAH/2017/31434
  • Walia K, Madhumathi J, Veeraraghavan B, et al. Establishing antimicrobial resistance surveillance & research network in India: journey so far. Indian J Med Res. 2019;149(2):164. doi:10.4103/ijmr.IJMR_226_1831219080
  • Cheesbrough M. District Laboratory Practice in Tropical Countries, Part 2. Cambridge university press; 2006.
  • Zowawi HM, Harris PNA, Roberts MJ, et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015;12(10):570. doi:10.1038/nrurol.2015.19926334085
  • Khushbu Y, Satyam P. Bacteriological profile of lower respiratory tract infection (LRTI) among HIV seropositive cases in Central Terai of Nepal. Int J Curr Microbiol Appl Sci. 2015;4(11):431–442.
  • Wayne PA. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI supplements M 100 2019.
  • Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1–94.29955859
  • Gupta R, Malik A, Rizvi M, Ahmed M. Presence of metallo-beta-lactamases (MBL), extended-spectrum beta-lactamase (ESBL) & AmpC positive non-fermenting Gram-negative bacilli among Intensive Care Unit patients with special reference to molecular detection of blaCTX-M & bla AmpC genes. Indian J Med Res. 2016;144(2):271. doi:10.4103/0971-5916.19504327934808
  • Beyene D, Bitew A, Fantew S, Mihret A, Evans M. Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One. 2019;14(9):e0222911. doi:10.1371/journal.pone.022291131553773
  • Uc-Cachón AH, Gracida-Osorno C, Luna-Chi IG, Jiménez-Guillermo JG, Molina-Salinas GM. High prevalence of antimicrobial resistance among Gram-negative isolated bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico. Med. 2019;55(9):588.
  • Singh N, Pattnaik D, Neogi DK, Jena J, Mallick B. Prevalence of ESBL in Escherichia coli isolates among ICU patients in a tertiary care hospital. JCDR. 2016;10(9).
  • Kayastha K, Dhunge B, Karki S, et al. Extended-Spectrum β-Lactamase-producing Escherichia coli and Klebsiella Species in pediatric patients visiting international friendship children’s Hospital, Kathmandu, Nepal. Infect Dis Res Treat. 2020;13:1–7.
  • Kovacevic P, Zlojutro B, Kovacevic T, Baric G, Dragic S, Momcicevic D. Microorganisms profile and antibiotics sensitivity patterns in the only medical intensive care unit in Bosnia and Herzegovina. Microb Drug Resist. 2019;25(8):1176–1181. doi:10.1089/mdr.2018.045831120362
  • Siddique SG, Bhalchandra MH, Wyawahare AS, Bansal VP, Mishra JK, Naik SD. Prevalence of MRSA, ESBL and Carbapenemase producing isolates obtained from endotracheal and tracheal tubes secretions of ICU patient at tertiary care centre. Int J Curr Microbiol App Sci. 2017;6(4):288–299. doi:10.20546/ijcmas.2017.604.032
  • Kano CU. Carbapenem-Resistant Enterobacteriaceae (CRE) in Intensive Care Units and surgical wards of hospitals with no history of carbapenem usage in Kano, North West Nigeria. Niger J Microbiol. 2015;27(1):2612–2618.
  • Moolchandani K, Sastry AS, Deepashree R, Sistla S, Harish BN, Mandal J. Antimicrobial resistance surveillance among Intensive Care Units of a Tertiary Care Hospital in Southern India. J Clin Diagn Res. 2017;11(2):DC01–DC07. doi:10.7860/JCDR/2017/23717.9247
  • Pilmis B, Zahar JR. Ventilator-associated pneumonia related to ESBL-producing gram negative bacilli. Ann Transl Med. 2018;6(21):424. doi:10.21037/atm.2018.09.3430581832
  • Sid Ahmed MA, Bansa D, Acharya A, et al. Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar. Antimicrob Resist Infect Control. 2016;5:4. doi:10.1186/s13756-016-0103-x26865975
  • Oberoi L, Singh N, Sharma P, Aggarwal A. ESBL, MBL and Ampc β lactamases producing superbugs–Havoc in the Intensive Care Units of Punjab India. JCDR. 2013;7(1):70. doi:10.7860/JCDR/2012/5016.267323450498
  • Saeed NK, Kambal AM, El-Khizzi NA. Antimicrobial-resistant bacteria in a general intensive care unit in Saudi Arabia. Saudi Med J. 2010;31(12):1341–1349.21135998
  • Saharman YR, Lestari DC. Phenotype characterization of beta-lactamase producing enterobacteriaceae in the intensive care unit (ICU) of CiptoMangunkusumo hospital in 2011. Acta Med Indonesiana. 2016;45(1).
  • Hecini-Hannachi A, Bentchouala C, Lezzar A, et al. Multidrug-resistant bacteria isolated from patients hospitalized in Intensive Care Unit in University Hospital of Constantine, Algeria. Afr J Microbiol Res. 2016;10(33):1328–1336. doi:10.5897/AJMR2016.8257
  • Leite CA, Oizumi KY, Caleffi-Ferracioli KR, et al. β - lactamase producing Gram-negative bacteria in an intensive care unit in southern Brazil. Brazilian J Pharm Sci. 2017;53(2).
  • Shrestha UT, Shrestha S, Adhikari N, et al. Plasmid profiling and occurrence of β-lactamase enzymes in multidrug-resistant uropathogenic Escherichia coli in Kathmandu, Nepal. Infect Drug Resist. 2020;13.
  • Chang YY, Chuang YC, Siu LK, et al. Clinical features of patients with carbapenem non-susceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect. 2015;48(2):219–225. doi:10.1016/j.jmii.2014.05.01025074627
  • Zaha DC, Kiss R, Hegedűs C, et al. Recent advances in investigation, prevention, and management of healthcare-associated infections (HAIs): resistant multidrug strain colonization and its risk factors in an Intensive Care Unit of a University Hospital. Biomed Res Int. 2019;2019:2019. doi:10.1155/2019/2510875
  • Liao CH, Lee NY, Tang HJ, et al. Antimicrobial activities of ceftazidime-avibactam, ceftolozane- tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016. Infect Drug Resist. 2019;12:545. doi:10.2147/IDR.S19363830881060
  • Muktan B, Shrestha UT, Dhungel B, et al. Plasmid mediated colistin resistant mcr-1 and co-existence of OXA-48 among Escherichia coli from clinical and poultry isolates: first report from Nepal. Gut Pathog. 2020;12:44. doi:10.1186/s13099-020-00382-532963589
  • Daef EA, Elsherbiny NM. Clinical and microbiological profile of nosocomial infections in adult intensive care units at Assiut University hospitals, Egypt. J Am Sci. 2012;8(12):1239–1250.
  • Wilson J. Surgical site infection: the principles and practice of surveillance. Part 1: key concepts in the methodology of SSI surveillance. J Infect Prev. 2013;14(1):6–12. doi:10.1177/1757177412471147